Dr. Reddy’s Laboratories Ltd

Hyderabad, Sept.17 (Maxim News): Dr. Reddy’s Laboratories Ltd. today announced the launch of over-the-counter (OTC) Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2% and 0.1%, the store-brand equivalents of Pataday Once Daily Relief…

Hyderabad, Sept.7 (Maxim News): Dr. Reddy’s Laboratories Ltd. today announced the launch of Fulvestrant Injection, 250 mg/5 mL (50 mg/mL) per Single-dose Syringe, a therapeutic equivalent generic version of Faslodex (fulvestrant) Injection,…

Hyderabad, Aug.27 (Maxim News): Dr. Reddy’s Laboratories today announced the launch of Penicillamine Capsules USP, 250 mg, a therapeutic equivalent generic version of Cuprimine (penicillamine) Capsules, 250 mg, approved by the U.S. Food and…

Hyderabad, Aug.25 (Maxim News): Dr. Reddy’s Laboratories Ltd today announced the entry into the hospital nutrition segment with the launch of its nutrition drink, ‘Celevida Maxx’ in India.

Hyderabad, May 18 (Maxim News): Dr. Reddy’s Laboratories Ltd launched FXR a therapeutic equivalent generic version of Ocaliva (obeticholic acid) in India, indicated for the treatment of Primary Biliary Cholangitis (PBC), in combination with…